|
|
| CrossRef Text and Data Mining | |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. | |
| Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse | |
| Tsz Wai Catherine Wong, Man Yee Shirley Wong | |
|
Ann Pediatr Endocrinol Metab. 2022;27(4):308-314. Published online December 31, 2022 DOI: https://doi.org/10.6065/apem.2244038.019 |
|
|
Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse” Annals of Pediatric Endocrinology & Metabolism. 2022;27(4):245-246  Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse Annals of Pediatric Endocrinology & Metabolism. 2022;27(4):308-314 Predicting the Risk of Graves Disease Relapse: Commentary on “Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease” Endocrine Practice. 2020;26(9):1039-1041 Clinical Features and Remission Rate of Pediatric Graves’ Hyperthyroidism Treated With Antithyroid Drug Journal of the Endocrine Society. 2021;5(Supplement_1):A710-A711 Valuable predictive features of relapse of Graves’ disease after antithyroid drug treatment Annales d'Endocrinologie. 2015;76(6):679-683 Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves’ disease Clinical Endocrinology. 2003;58(4):403-408 Thyroid Peroxidase Antibody Positivity is Associated With Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease Endocrine Practice. 2020;26(9):1026-1030 Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy Endocrinology and Metabolism. 2019;34(3):268 Optimizing remission rates using antithyroid drugs for Graves’ disease Clinical Endocrinology. 2009;72(6):729-730 The effect of prior antithyroid drug use on delaying remission in high uptake Graves' disease following radioiodine ablation Endocrine Connections. 2016;5(1):34-40 |
